Ignite Creation Date:
2025-12-24 @ 4:04 PM
Ignite Modification Date:
2026-01-29 @ 12:58 PM
Study NCT ID:
NCT01466166
Status:
COMPLETED
Last Update Posted:
2019-01-11
First Post:
2011-10-28
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Observational Study of the Use of Pegloticase (KRYSTEXXA®) in Refractory Chronic Gout
Sponsor:
Horizon Pharma Rheumatology LLC
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
M0401
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None